Compass Therapeutics, Inc.CMPXNASDAQ
Loading
Year-over-year operating cash flow growth rate
Percentile
P27
Within normal range
vs 5Y Ago
-2.7x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -22.17% |
| Q3 2025 | 8.31% |
| Q2 2025 | 10.42% |
| Q1 2025 | -44.16% |
| Q4 2024 | 17.09% |
| Q3 2024 | -2.76% |
| Q2 2024 | 22.57% |
| Q1 2024 | -12.42% |
| Q4 2023 | -108.61% |
| Q3 2023 | 41.44% |
| Q2 2023 | 17.30% |
| Q1 2023 | -14.92% |
| Q4 2022 | 2.75% |
| Q3 2022 | -137.87% |
| Q2 2022 | 42.08% |
| Q1 2022 | -70.25% |
| Q4 2021 | -34.94% |
| Q3 2021 | 41.79% |
| Q2 2021 | -5.96% |
| Q1 2021 | 14.73% |
| Q4 2020 | 8.31% |
| Q3 2020 | -35.26% |
| Q2 2020 | 31.71% |
| Q1 2020 | -38.81% |
| Q4 2019 | 16.60% |
| Q3 2019 | -74646.35% |
| Q2 2019 | 14.39% |
| Q1 2019 | 0.00% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |